Auna SA
$5.52
▲
0.71%
2026-04-21 05:29:00
www.aunainvestors.com
NYQ: AUNA
Explore Auna SA stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$415.95 M
Current Price
$5.52
52W High / Low
$7.39 / $4.46
Stock P/E
14.63
Book Value
$6.11
Dividend Yield
—
ROCE
14.53%
ROE
6.54%
Face Value
—
EPS
$0.38
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
—
Beta
1.64
Debt / Equity
223.1
Current Ratio
1.11
Quick Ratio
0.8
Forward P/E
5.16
Price / Sales
0.1
Enterprise Value
$4.18 B
EV / EBITDA
5.1
EV / Revenue
0.95
Rating
Buy
Target Price
$7.2
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Leverage is relatively high.
- Current ratio suggests tighter short-term liquidity.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 2. | Strata Critical Medical, Inc. | $4.52 | 9.61 | $397.54 M | — | -7.31% | -8.01% | $6.02 / $2.51 | $4.18 |
| 3. | Aveanna Healthcare Holdings Inc. | $6.87 | 6.54 | $1.47 B | — | 16.39% | 6.16% | $10.32 / $3.73 | $0.93 |
| 4. | Cross Country Healthcare, Inc. | $9.96 | — | $317.69 M | — | -1.05% | -25.57% | $14.99 / $7.43 | $10.18 |
| 5. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 6. | AirSculpt Technologies, Inc. | $2.64 | — | $180.6 M | 0% | -0.99% | -14.06% | $12 / $1.51 | $1.36 |
| 7. | Healthcare Services Group, Inc. | $19.32 | 22.48 | $1.33 B | — | 8.94% | 11.69% | $22.98 / $9.12 | $7.33 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | — | 1.12 B | 1.09 B | 1.04 B | 1.06 B | 1.13 B |
| Operating Profit | — | 160 M | 172 M | 145.56 M | 198.16 M | 199.65 M |
| Net Profit | — | 48 M | 81.98 M | 35.43 M | 21.96 M | 97.89 M |
| EPS in Rs | -0.92 | 1.59 | 2.72 | 1.18 | 0.73 | 3.25 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 4.39 B | 3.88 B | 2.45 B | 1.92 B |
| Operating Profit | 746.18 M | 545.73 M | 243.14 M | 127.98 M |
| Net Profit | 110.27 M | -253.92 M | -85.61 M | -26.47 M |
| EPS in Rs | 3.66 | -8.44 | -2.84 | -0.88 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 7.08 B | 7.69 B | 6.59 B | 2.82 B |
| Total Liabilities | 5.46 B | 5.91 B | 5.04 B | 2.28 B |
| Equity | 1.48 B | 1.47 B | 1.06 B | 495.82 M |
| Current Assets | 1.7 B | 1.55 B | 1.2 B | 671.27 M |
| Current Liabilities | 1.95 B | 1.69 B | 2.85 B | 698.49 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | 668.5 M | 582.41 M | 162.64 M | 183.34 M |
| Investing CF | -236.82 M | -173.15 M | -3.21 B | -291.99 M |
| Financing CF | -418.12 M | -370 M | 3.13 B | -102.13 M |
| Free CF | 526.65 M | 417.25 M | 10.67 M | -106.03 M |
| Capex | -141.85 M | -165.16 M | -151.97 M | -289.37 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.16% | 58.1% | 27.44% | — |
| Earnings Growth % | 143.43% | -196.62% | -223.37% | — |
| Profit Margin % | 2.51% | -6.55% | -3.49% | -1.38% |
| Operating Margin % | 17.01% | 14.08% | 9.92% | 6.65% |
| Gross Margin % | 39.34% | 37.03% | 35.88% | 35.71% |
| EBITDA Margin % | 20.22% | 16.7% | 12.2% | 8.84% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.